Related Experiment Video
Updated: Dec 5, 2025

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
Coronary Cannulation After Transcatheter Aortic Valve Replacement: The RE-ACCESS Study
Marco Barbanti1, Giuliano Costa1, Andrea Picci1
1Division of Cardiology, A.O.U. Policlinico-San Marco, Catania, Italy.
Insights
Coronary cannulation after transcatheter aortic valve replacement (TAVR) is feasible in most cases, but Evolut TAVs increase the risk of failure. Specific factors predict and help manage this complication.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Devices
Background:
- Coronary ostia cannulation after transcatheter aortic valve replacement (TAVR) is crucial for managing potential complications.
- Limited data exists on the feasibility and reproducibility of coronary cannulation post-TAVR.
Purpose of the Study:
- To investigate the feasibility of coronary ostia cannulation after TAVR.
- To identify predictors of impaired coronary access following TAVR.
Main Methods:
- Prospective, single-center registry study (RE-ACCESS) of consecutive patients undergoing TAVR.
- Coronary angiography performed before and after TAVR.
- Primary endpoint: rate of unsuccessful coronary ostia cannulation post-TAVR; Secondary endpoints: factors associated with cannulation failure.
Main Results:
- Unsuccessful coronary cannulation occurred in 7.7% of 300 patients.
- Evolut R/PRO transcatheter aortic valves (TAVs) were associated with 17.9% failure rate versus 0.4% for other TAVs (p < 0.01).
- Independent predictors of failure included Evolut TAV use, TAV-sinus of Valsalva relation, and TAV implantation depth.
Conclusions:
- Unsuccessful coronary cannulation post-TAVR is infrequent but significantly higher with Evolut TAVs.
- A predictive model combining Evolut TAV use, sinus relation, and implantation depth accurately identifies patients at risk.
- These findings aid in anticipating and managing coronary access challenges after TAVR.
Objectives:
The aims of this study were to investigate the feasibility of coronary ostia cannulation after transcatheter aortic valve replacement (TAVR) and to assess potential predictors of coronary access impairment.
Background:
Certain data concerning the feasibility and reproducibility of coronary cannulation after TAVR are lacking.
Methods:
RE-ACCESS (Reobtain Coronary Ostia Cannulation Beyond Transcatheter Aortic Valve Stent) was an investigator-driven, single-center, prospective, registry-based study that enrolled consecutive patients undergoing TAVR using all commercially available devices. All patients underwent coronary angiography before and after TAVR. The primary endpoint was the rate of unsuccessful coronary ostia cannulation after TAVR. Secondary endpoints were the identification of factors associated with the inability to selectively cannulate coronary ostia after TAVR.
Results:
Among 300 patients enrolled in the RE-ACCESS study from December 2018 to January 2020, a total of 23 cases (7.7%) of unsuccessful coronary cannulation after TAVR were documented. This issue occurred in 22 of 23 cases with the use of Evolut R/PRO transcatheter aortic valves (TAVs) (17.9% vs. 0.4%; p < 0.01). In multivariate analysis, the use of Evolut R/PRO TAVs (odds ratio [OR]: 29.6; 95% confidence interval [CI]: 2.6 to 335.0; p < 0.01), the TAV-sinus of Valsalva relation (OR: 1.1 per 1-mm increase; 95% CI: 1.0 to 1.2; p < 0.01), and the mean TAV implantation depth (OR: 1.7 per 1-mm decrease; 95% CI: 1.3 to 2.3; p < 0.01) were found to be independent predictors of unsuccessful coronary cannulation after TAVR. A model combining these factors was demonstrated to predict with very high accuracy the risk for unsuccessful coronary cannulation after TAVR (area under the curve: 0.94; p < 0.01).
Conclusions:
Unsuccessful coronary cannulation following TAVR was observed in 7.7% of patients and occurred almost exclusively in those receiving Evolut TAVs. The combination of Evolut TAV, a higher TAV-sinus of Valsalva relation, and implantation depth predicts with high accuracy the risk for unsuccessful coronary cannulation after TAVR. (Reobtain Coronary Ostia Cannulation Beyond Transcatheter Aortic Valve Stent [RE-ACCESS]; NCT04026204).
More Related Videos
06:59Improved Registration of 3D CT Angiography with X-ray Fluoroscopy for Image Fusion During Transcatheter Aortic Valve Implantation
Published on: June 3, 2018
08:50Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
Related Concept Videos
Cardiac Catheterization IV: Nursing Management
Cardiac Catheterization III: Left Heart Catheterization
Cardiac Catheterization II: Right Heart Catheterization
Cardiac Catheterization I: Pre-Procedure Overview
Coronary Artery Disease V: Interprofessional Care